Print

Print


 
-----Original Message-----
From: Ellis, Graham 
Sent: 04 May 2007 12:39
To: McCullough, Derreck Dr.
Subject: FW: Total Bilirubin on the Abbott Aeroset



 

 

  _____  

From: Ellis, Graham 
Sent: 04 May 2007 10:42
To: McCombe, Stephen
Subject: Total Bilirubin on the Abbott Aeroset

 

Dear List Members

 

Many Aeroset users may be aware of the interference by indoxyl sulphate
(found in the serum of patients with severe renal disease) on the "new"
Abbott total bilirubin (diazo) method. (6L45-20 or 6L45-40).

The method was designed to replace the oxidation method 7D60-02.

 

Abbott state in the pack insert that the addition of 0.25 mmol/L indoxyl
sulphate to specimens increased the total bilirubin by a maximum of 1.5
mg/dL. Read casually, this may not seem important (even if you realize that
1.5 mg/dL is 25.7 mmol/L).  We are all used to adding a few hundred mg of
cholesterol to steroid assays and the cross reactivity making no difference.

 

However after changing to the diazo method, our renal physician contacted us
almost immediately to ask what had happened to the bilirubin method?

Patients on haemodialysis monitored regularly, suddenly showed an increase
in bilirubin.

 

We have moved back to the oxidation method, pending a "fix" from Abbott for
the diazo method. While we had both methods on our Aerosets, we did a very
brief comparison, shown below (oxidation method in brackets) in umol/L:

 

Normal (non-renal unit) patients: 24 (20), 11 (10), 30 (27), 22 (20), 25
(24).

 

Renal Unit (haemodialysis): 19 (5), 30 (4), 34 (5), 23 (3), 15 (5), 36 (3),
21 (3)

 

Graham Ellis and Stephen McCombe

St. John's Hospital

Livingston

West Lothian


*****************************************************************
The information contained in this message may be confidential or 
legally privileged and is intended for the addressee only. If you 
have received this message in error or there are any problems 
please notify the originator immediately. The unauthorised use, 
disclosure, copying or alteration of this message is 
strictly forbidden.
*****************************************************************


------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/